Literature DB >> 27729393

Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture.

Eric Piver1,2, Audrey Boyer1,3, Julien Gaillard4, Anne Bull1, Elodie Beaumont1, Philippe Roingeard1,4, Jean-Christophe Meunier1.   

Abstract

OBJECTIVE: HCV particles are associated with very low-density lipoprotein components in chronically infected patients. These hybrid particles, or 'lipo-viro particles' (LVPs), are rich in triglycerides, and contain the viral RNA, the capsid protein, E1E2 envelope glycoproteins and apolipoproteins B and E. However, their specific ultrastructural organisation has yet to be determined. We developed a strategy for the preparation of any viral sample that preserves the native structure of the LVPs, facilitating their precise morphological characterisation.
DESIGN: Using a strategy based on the direct specific immunocapture of particles on transmission electron microscopy (TEM) grids, we characterised the precise morphology of the viral particle by TEM.
RESULTS: The LVP consists of a broad nucleocapsid surrounding an electron-dense centre, presumably containing the HCV genome. The nucleocapsid is surrounded by an irregular, detergent-sensitive crescent probably composed of lipids. Lipid content may determine particle size. These particles carry HCV E1E2, ApoB and ApoE, as shown in our immuno-EM analysis. Our results also suggest that these putative LVPs circulate in the serum of patients as part of a mixed population, including lipoprotein-like particles and complete viral particles.
CONCLUSIONS: Twenty-five years after the discovery of HCV, this study finally provides information about the precise morphological organisation of viral particles. It is truly remarkable that our TEM images fully confirm the ultrastructure of LVPs predicted by several authors, almost exclusively from the results of molecular biology studies. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  HCV; HEPATITIS C; IMAGING; INFECTIOUS DISEASE; LIPID METABOLISM

Mesh:

Substances:

Year:  2016        PMID: 27729393     DOI: 10.1136/gutjnl-2016-311726

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus.

Authors:  Holly Freedman; Michael R Logan; Darren Hockman; Julia Koehler Leman; John Lok Man Law; Michael Houghton
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes.

Authors:  Sandrine Belouzard; Adeline Danneels; Lucie Fénéant; Karin Séron; Yves Rouillé; Jean Dubuisson
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

3.  TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.

Authors:  Audrey Boyer; Seung Bum Park; Ynto S de Boer; Qisheng Li; T Jake Liang
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

Review 4.  Hepatitis C Virus Uses Host Lipids to Its Own Advantage.

Authors:  Malgorzata Sidorkiewicz
Journal:  Metabolites       Date:  2021-04-27

Review 5.  Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

Authors:  Emilie Crouchet; Thomas F Baumert; Catherine Schuster
Journal:  Expert Rev Proteomics       Date:  2017-06-30       Impact factor: 4.250

6.  Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity.

Authors:  Katharina Herzog; Simonetta Bandiera; Sophie Pernot; Catherine Fauvelle; Frank Jühling; Amélie Weiss; Anne Bull; Sarah C Durand; Béatrice Chane-Woon-Ming; Sébastien Pfeffer; Marion Mercey; Hervé Lerat; Jean-Christophe Meunier; Wolfgang Raffelsberger; Laurent Brino; Thomas F Baumert; Mirjam B Zeisel
Journal:  Gut       Date:  2019-05-10       Impact factor: 31.793

7.  Newly discovered hepatitis C virus minicores circulate in human blood.

Authors:  Francis J Eng; Ahmed El-Shamy; Erin H Doyle; Arielle Klepper; A Scott Muerhoff; Andrea D Branch
Journal:  Hepatol Commun       Date:  2017-11-12

8.  Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric fah-/- Mice.

Authors:  Ursula Andreo; Ype P de Jong; Margaret A Scull; Jing W Xiao; Koen Vercauteren; Corrine Quirk; Michiel C Mommersteeg; Sonia Bergaya; Arjun Menon; Edward A Fisher; Charles M Rice
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-07-19

Review 9.  Hepatitis C Virus Structure: Defined by What It Is Not.

Authors:  Altaira D Dearborn; Joseph Marcotrigiano
Journal:  Cold Spring Harb Perspect Med       Date:  2020-01-02       Impact factor: 6.915

10.  Role of cleavage at the core-E1 junction of hepatitis C virus polyprotein in viral morphogenesis.

Authors:  Véronique Pène; Matthieu Lemasson; Francis Harper; Gérard Pierron; Arielle R Rosenberg
Journal:  PLoS One       Date:  2017-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.